Professor Kevin Fenton CBE

Professor Kevin Fenton is a leading public health expert and infectious disease epidemiologist who has worked in a variety of public health executive leadership roles across government and academia in the UK and internationally.

He was named the second most influential black person in Britain by Powerlist in November 2020 for his pivotal role against COVID-19 and tackling inequalities. He was also awarded a CBE in the 2022 New Year honours list for services to public health.   

Kevin is the current President of The British Science Association (BSA). He is also the Regional Director for London in the Office for Health Improvement and Disparities (OHID) within the Department of Health and Social Care (DHSC), Kevin focuses on tackling health inequalities, infectious disease prevention and control, climate justice and urban health.

Professor Fenton became the Regional Director for London in the Office for Health Improvement and Disparities (OHID) within the Department of Health and Social Care (DHSC) in October 2021, having previously held the same position within Public Health England from April 2020 until its functions transferred to OHID. Within this role, he is also the statutory public health advisor to the Mayor of London and the Greater London Authority and the Regional Director of Public Health for NHS London. He provides leadership across London for health and wellbeing, prevention of ill health, health protection and reduction of health inequalities. In December 2021, Professor Fenton was appointed Chief Advisor on HIV to Government and Chair of the HIV Action Plan Implementation Steering Group to oversee the delivery of the new HIV strategy for England.

Professor Fenton previously held a joint position as Strategic Director of Place and Wellbeing and Director of Public Health at London Borough of Southwark. In this role he led the council’s planning, regeneration, community engagement and public health portfolios driving inclusive regeneration, digital public health, asset-based community development and working in partnership with the NHS to promote health in all policies.

From 2012 to 2017, Kevin was PHE’s National Director for Health and Wellbeing, leading national prevention programmes including screening for cancer, NHS Health Checks, obesity, mental health, e-cigarettes and tobacco harm reduction, HIV, sexual and reproductive health. He established and led PHE’s Health Equity programme, focused on addressing the social determinants of health and promoting place-based approaches to health improvement.

Between 2005 and 2012, Professor Fenton was the Director of the National Centre for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), within the Centres for Disease Control and Prevention (CDC) in America. He also served as chief of CDC’s National Syphilis Elimination Effort, having worked in research, epidemiology, and the prevention of HIV and other STDs since 1995. Between 2000 and 2004, he was Director of the HIV and STI Department in the United Kingdom’s Health Protection Agency and Senior Lecturer in HIV and STI epidemiology and control at University College London.